BIOA – bioage labs, inc. (US:NASDAQ)
Stock Stats
News
BioAge Labs Touts Oral NLRP3 Inhibitor BGE-102 Data, Eyes CV Study and Retinal Expansion [Yahoo! Finance]
BioAge Labs (BIOA) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $60.00 price target on the stock.
BioAge Labs to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
BioAge Labs to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
Invitation to presentation of BioArctic's fourth quarter report for October - December 2025 on February 18 at 9.30 a.m. CET
Form 4 BioAge Labs, Inc. For: Mar 02 Filed by: RUBIN PAUL D
Form 4 BioAge Labs, Inc. For: Mar 01 Filed by: GOLDSTEIN DOV A MD
Form 144 BioAge Labs, Inc. Filed by: RUBIN PAUL D
Form 4 BioAge Labs, Inc. For: Feb 17 Filed by: RUBIN PAUL D
Form 4 BioAge Labs, Inc. For: Feb 17 Filed by: Morgen Eric
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.